OMass Therapeutics is an Oxford, UK biotechnology company developing medicines for immunological and rare diseases. It harnesses proprietary biochemistry, native mass spectrometry and custom chemistry through its OdyssION drug discovery platform to interrogate drug targets and how they interact with their native biological ecosystem, separate from… - View it on GitHub